DIRS.INFO The most relevant business & tech news

The effort against Issue 1, which would amend the constitution to protect abortion rights, raised just under $10 million in the same period, according to Thursday's filings. The campaign against Issue 1, called Protect Women Ohio, accepted more than half its donations in the final months of the race from Protect Women Ohio Action Inc., a committee associated with the anti-abortion group Susan B. Anthony Pro-Life America. It's been harder for campaigns against abortion rights to get traction, Lenkowsky said. In Ohio, an August special election that would have swayed November's election went in the direction of abortion rights supporters, which likely made anti-abortion donors less willing to keep giving. Amy Natoce, press secretary of Protect Women Ohio, criticized the pro-Issue 1 campaign's outside funding in a statement to The Associated Press.

Persons: Hansjörg Wyss, George Soros, Michael Bloomberg, Abigail Wexner, Les Wexner, Susan B, Anthony Pro, Roe, Wade, Leslie Lenkowsky, It's, Lenkowsky, Amy Natoce, “ It’s, ”, “, Martin Haskell, Julie Carr Smyth, Christine Fernando Organizations: Washington , D.C, United, Reproductive Rights, New, Society Policy Center, American Civil Liberties Union, Brands, Protect, Protect Women, Inc, America, Supreme, Indiana University, Associated Press, Ohioans United, AP Locations: Ohio, Washington ,, Swiss, New York, Columbus, U.S, In Ohio, Protect Women Ohio, Columbus , Ohio, Chicago

☆ Bristol-Myers Squibb to acquire Mirati in up to $5.8 billion deal
▼ + stars: | 2023-10-09 | by ( Michael Erman | ) www.reuters.com time to read: +3 min

REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing RightsOct 8 (Reuters) - Bristol-Myers Squibb (BMY.N) on Sunday said it will acquire cancer drugmaker Mirati Therapeutics (MRTX.O) for up to $5.8 billion, diversifying its oncology business and adding drugs it hopes can help offset expected lost revenue from patent expirations later this decade. Bristol will pick up Mirati's portfolio drugs that target the genetic drivers of specific cancers including its lung cancer drug, Krazati, which was approved in December. The company said that it will buy Mirati for $58 per share in cash, or around $4.8 billion. Mirati has around $1.1 billion in cash on hand, so "we're paying essentially $3.7 billion enterprise value...we think with that we've gotten a very attractive deal," Lenkowsky said. Last year, Bristol acquired drug developer Turning Point Therapeutics for $4.1 billion in cash to help bolster its arsenal of cancer drugs.

Persons: Bristol Myers, Dado Ruvic, Adam Lenkowsky, Mirati, we've, Lenkowsky, Chris Boerner, Giovanni Caforio, Boerner, Lavanya Ahire, Lisa Shumaker, Diane Craft, Andrea Ricci, Michael Perry Organizations: Bristol, Bristol Myers Squibb, REUTERS, Myers Squibb, Therapeutics, U.S . Food, Drug Administration, Bristol Myers, Thomson Locations: Bristol, U.S, New York

☆ Bristol Myers CEO Caforio steps down
▼ + stars: | 2023-04-26 | by ( ) www.reuters.com time to read: +1 min

[1/2] A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File PhotoCompanies Bristol-Myers Squibb Co FollowApril 26 (Reuters) - Bristol Myers Squibb Co (BMY.N) said on Wednesday CEO Giovanni Caforio, who has been in the role since 2015, has decided to step down from his position. Outgoing CEO Giovanni will continue as executive chairman of the company's board. Bristol Myers is due to report first-quarter financial results on Thursday. Bristol Myers shares rose 0.39% to $68.29 in after-hours trading.

☆ ‘The Bill of Obligations’ Review: We’re All in This Together
▼ + stars: | 2023-03-02 | by ( Leslie Lenkowsky | ) www.wsj.com time to read: +1 min

Just half of the public said that they had helped friends or neighbors informally during the year—e.g., lending tools, tending children—and few did so frequently. Since pandemic social-distancing rules were operating in parts of the country in this period, such findings are not entirely surprising. But they also reflect trends with a longer arc, such as the decadeslong decline in the membership of social and civic groups. The U.S. seems to have gone from “a nation of joiners” (as the historian Arthur Schlesinger Sr. put it in 1944) to “a nation of spectators” (as a blue-ribbon commission declared at the end of the 1990s). More than a few people, following a theme in Tocqueville’s “Democracy in America,” worry that reduced social involvement will weaken the skills and customs needed for democratic government.

Search resuls for: "Lenkowsky"

4 mentions found